Scrum levels of IL-13 were significantly lower in COAD patients in an advanced stage, and this was associated with a poorer prognosis.[59] These studies confirmed that up-regulated IL-4/IL-13 pathway inevitably suppressed the progression of COAD. Here, IL13 is linked to colon adenocarcinoma.